RUNX2 and gastric adenocarcinoma: In addition, with STAD development, the expression level of ETS1 was significantly upregulated in advanced stages (stages II, III, and IV), and the expression level of RUNX2 was significantly upregulated in stages III and IV (P < 0.05, Fig. 4B).